You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

exenatide LAR

Showing 1 - 25 of 398
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Guadalajara (Exenatide LAR, Dulaglutide)

Unknown status
  • Diabetes Mellitus, Type 2
  • Guadalajara, Jalisco, Mexico
    Instituto de terapeutica Experimental y Clinica. Centro universi
Mar 24, 2020

Atherosclerosis, Diabetes, Restenosis Trial in Stockholm (Bydureon, Humulin kwickpen, Metformin)

Recruiting
  • Atherosclerosis
  • +2 more
  • Stockholm, Other, Sweden
    Dept of clinical science and education Karolinska Institutet Söd
Aug 31, 2021

Dysglycemia, Cognitive Deficit Trial in Parma (Exenatide, )

Active, not recruiting
  • Dysglycemia
  • Cognitive Deficit
  • Parma, Italy
  • +1 more
Aug 10, 2021

Colorectal Cancer, Stoma Ileostomy Trial (Diverting loop ileostomy)

Not yet recruiting
  • Colorectal Cancer
  • Stoma Ileostomy
  • Diverting loop ileostomy
  • (no location specified)
Nov 21, 2023

Smoking Cessation, Weight Gain Trial in Houston (Exenatide 2 milligram (mg) Injection, Placebo, Nicotine patch)

Not yet recruiting
  • Smoking Cessation
  • Weight Gain
  • Exenatide 2 milligram (mg) Injection
  • +3 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Nov 2, 2022

Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)

Terminated
  • Type 2 Diabetes
  • Exenatide Injection
  • Saline injection
  • Lancaster, Pennsylvania
    Amish Research Clinic
Mar 6, 2023

Low Anterior Resection Syndrome in Newly Diagnosed Rectal

Recruiting
  • Rectal Cancer
    • Taoyuan City, Kwei-Shan Dist., Taiwan
      Chung Gung University
    Jun 30, 2022

    Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Trastuzumab Deruxtecan
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jul 12, 2023

    Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour Trial in Worldwide (Octreotide LAR, 177Lu-DOTA0-Tyr3-Octreotate)

    Completed
    Has Results
    • Carcinoid Tumor of the Small Bowel
    • Neuroendocrine Tumour
    • Los Angeles, California
    • +38 more
    Mar 10, 2022

    WIReD: Wireless Interstage Remote Device Study

    Not yet recruiting
    • Congenital Heart Disease in Children
    • +3 more
    • Gabi SmartCare Pediarity System [Gabi Band, Gabi Monitor App, Gabi Analytics]
    • Kansas City, Missouri
      Children's Mercy Hospital
    Jul 27, 2023

    Parkinson's Disease Trial in Gainesville (Exenatide)

    Completed
    • Parkinson's Disease
    • Gainesville, Florida
      Laboratory for Rehabilitation Neuroscience
    Sep 14, 2022

    Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 25, 2023

    Gestational Diabetes Trial (Exenatide)

    Not yet recruiting
    • Gestational Diabetes
    • (no location specified)
    Jul 28, 2022

    Pre-diabetes, Type 2 Diabetes Trial in Philadelphia (Exenatide, Sitagliptin, Glimepiride)

    Completed
    Has Results
    • Pre-diabetes
    • Type 2 Diabetes
    • Philadelphia, Pennsylvania
    • +2 more
    May 16, 2022

    Type 2 Diabetes Trial (NPM-119 (exenatide implant), Bydureon BCise (exenatide extended release))

    Not yet recruiting
    • Type 2 Diabetes
    • NPM-119 (exenatide implant)
    • Bydureon BCise (exenatide extended release)
    • (no location specified)
    Jan 29, 2023

    LARS for Chinese Patients

    Completed
    • Incidence and Risk Factors of Low Anterior Resection Syndrome
    • LARS questionnaire
    • Guangzhou, Guangdong, China
      the Third Affiliated Hospital of Sun Yat-Sen University
    May 10, 2022

    A Pan-European Post-Authorisation Safety Study: Risk of

    Not yet recruiting
    • Pancreatic Cancer
    • Exenatide
    • Non-GLP-1 RA based glucose lowering drugs
    • (no location specified)
    Dec 21, 2022

    Rectal Cancer Trial in Seoul (Prune (dried plum))

    Completed
    • Rectal Cancer
    • Prune (dried plum)
    • Seoul, Gangnam-gu, Korea, Republic of
      Samsung Medical Center
    Jun 8, 2023

    Parkinson's Disease Trial in London (Exenatide extended release 2mg (Bydureon))

    Active, not recruiting
    • Parkinson's Disease
    • Exenatide extended release 2mg (Bydureon)
    • London, United Kingdom
      University College London Hospital
    May 18, 2022

    Neuroendocrine Tumors Trial in United States (Octreotide, LAR Lanreotide, Questionnaires)

    Active, not recruiting
    • Neuroendocrine Tumors
    • Basking Ridge, New Jersey
    • +6 more
    Apr 20, 2022

    Heart Transplant Rejection, Immune Suppression, Pediatric Heart Transplant Trial in Gainesville (DOT intervention)

    Not yet recruiting
    • Heart Transplant Rejection
    • +3 more
    • DOT intervention
    • Gainesville, Florida
      University of Florida
    Feb 8, 2023

    Cocaine Use Disorder Trial in Houston (Exenatide 2 mg [Bydureon], Drug Counseling)

    Completed
    Has Results
    • Cocaine Use Disorder
    • Exenatide 2 mg [Bydureon]
    • Drug Counseling
    • Houston, Texas
      UTHealth Behavioral and Biomedical Sciences Building
    May 31, 2022

    Heart Defects, Congenital, Pediatrics Trial in Kansas City (CHAMP App)

    Enrolling by invitation
    • Heart Defects, Congenital
    • Pediatrics
    • CHAMP App
    • Kansas City, Missouri
      Children's Mercy Hospital
    Sep 15, 2023

    Rectal Carcinoma Trial in Chongqing (Pelvic floor Reconstruction)

    Recruiting
    • Rectal Carcinoma
    • Pelvic floor Reconstruction
    • Chongqing, Chongqing, China
      General Surgery Center of PLA
    Nov 28, 2021

    Alcohol Use Disorder Trial in Boston (Exenatide, Sham injection)

    Terminated
    Has Results
    • Alcohol Use Disorder
    • Boston, Massachusetts
      Boston University Psychiatry Research Center, Clinical Studies U
    Jan 14, 2022